tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

Whitehawk Therapeutics Inc

WHWK
Add to Watchlist
4.200USD
+0.120+2.94%
Close 09-18 16:00（ET）
197.05MMarket Cap
LossP/E TTM

Whitehawk Therapeutics Inc

4.200
+0.120+2.94%
Overview
News&Analysis
Financials
Stock Score
Technical
Forecast
Ownership
Dividends
Profile
Discussions
Financial SummaryIncome StatementBalance SheetCash Flow StatementRevenueEarningsCompany ValuationRisk Assessment

Overview

News&Analysis

Financials

Stock Score

Technical

Forecast

Ownership

Dividends

Profile

Discussions

Financial SummaryIncome StatementBalance SheetCash Flow StatementRevenueEarningsCompany ValuationRisk Assessment

WHWK Financials

See Whitehawk Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Key Financial Ratios

Market Cap
197.05M
Dividend TTM
0.00
P/E TTM
-1.61
EPS TTM
-2.60
Revenue
7.14M
Net Profit
-63.69M
ROE
-68.54%
ROA
-64.12%

Whitehawk Therapeutics Inc Earnings Date

Latest Release
Aug 6, 2026
EPS / Forecast
--/-0.30
Revenue / Forecast
--/0.00

Financial Statement Highlights

Quarterly
Quarterly+Annual
Quarterly
Annual
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
Financial Indicators
EPS
73.64%-0.20
---0.32
---2.25
---0.26
---0.76
--1.84
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Revenue
--0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
33.48%7.14M
14.43%7.24M
21.03%7.21M
-0.37%6.18M
-8.76%5.35M
21.03%6.33M
40.38%5.96M
80.45%6.20M
154.31%5.87M
422.70%5.23M
--4.25M
--3.44M
--2.31M
--1.00M
-100.00%0.00
Net Profit
68.37%-16.64M
-130.40%-22.19M
-27.24%-23.25M
-41.45%-17.75M
-260.80%-52.62M
499.23%73.02M
-12.32%-18.27M
23.04%-12.55M
18.85%-14.58M
-20.14%-18.29M
-16.93%-16.27M
-12.63%-16.30M
1.63%-17.97M
-9.86%-15.22M
12.99%-13.91M
83.38%-14.47M
-314.46%-18.27M
-211.97%-13.86M
-238.94%-15.99M
-2911.34%-87.09M
Net Margin
----
----
----
----
----
--1021.92%
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Gross Margin
----
----
----
----
----
--89.36%
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Income Statement
Revenue
--0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
33.48%7.14M
14.43%7.24M
21.03%7.21M
-0.37%6.18M
-8.76%5.35M
21.03%6.33M
40.38%5.96M
80.45%6.20M
154.31%5.87M
422.70%5.23M
--4.25M
--3.44M
--2.31M
--1.00M
-100.00%0.00
Operating profit
66.92%-18.11M
-54.57%-23.52M
-31.34%-24.89M
-81.40%-19.55M
-251.32%-54.75M
22.01%-15.22M
-6.97%-18.95M
39.63%-10.78M
20.27%-15.58M
-15.97%-19.51M
-14.49%-17.71M
-18.71%-17.85M
-33.54%-19.55M
-21.80%-16.82M
2.97%-15.47M
-14.30%-15.04M
-206.75%-14.64M
-216.50%-13.81M
-182.88%-15.95M
-393.99%-13.15M
Net Profit
68.37%-16.64M
-130.40%-22.19M
-27.24%-23.25M
-41.45%-17.75M
-260.80%-52.62M
499.23%73.02M
-12.32%-18.27M
23.04%-12.55M
18.85%-14.58M
-20.14%-18.29M
-16.93%-16.27M
-12.63%-16.30M
1.63%-17.97M
-9.86%-15.22M
12.99%-13.91M
83.38%-14.47M
-314.46%-18.27M
-211.97%-13.86M
-238.94%-15.99M
-2911.34%-87.09M
Balance Sheet
Current assets
7.69%192.41M
-46.03%125.55M
143.14%149.01M
113.46%165.04M
92.11%178.67M
126.78%232.61M
-50.81%61.29M
-41.82%77.31M
-35.82%93.00M
-37.81%102.57M
-30.80%124.59M
-30.01%132.88M
16.56%144.92M
21.61%164.93M
19.01%180.03M
17.19%189.86M
232.49%124.33M
230.79%135.62M
238.27%151.27M
226.76%162.02M
Total current liabilities
26.42%11.07M
-9.92%11.06M
-14.96%14.52M
-37.72%9.85M
-60.46%8.76M
-38.24%12.27M
-35.31%17.07M
-22.93%15.81M
70.41%22.15M
11.99%19.88M
40.14%26.39M
14.68%20.52M
3.18%13.00M
54.19%17.75M
23.32%18.84M
54.67%17.89M
470.45%12.60M
440.58%11.51M
718.13%15.27M
360.48%11.57M
Total assets
7.28%193.99M
-45.63%127.23M
114.49%150.83M
94.89%167.02M
77.94%180.82M
110.67%234.00M
-46.90%70.32M
-38.64%85.70M
-32.80%101.62M
-34.91%111.07M
-28.12%132.42M
-28.05%139.66M
17.56%151.23M
19.91%170.65M
16.67%184.24M
15.01%194.10M
243.73%128.64M
245.76%142.32M
251.50%157.91M
238.69%168.77M
Total liabilities
26.42%11.07M
-9.92%11.06M
-18.62%14.52M
-41.48%9.85M
-61.65%8.76M
-40.46%12.27M
-34.48%17.84M
-21.59%16.83M
15.25%22.83M
-16.44%20.61M
5.29%27.23M
-14.13%21.46M
-0.49%19.81M
39.44%24.67M
20.25%25.86M
40.05%25.00M
801.50%19.91M
730.87%17.69M
1051.91%21.50M
610.48%17.85M
Total equity
6.31%182.93M
-47.60%116.17M
159.75%136.31M
128.22%157.17M
118.38%172.07M
145.11%221.73M
-50.11%52.48M
-41.73%68.87M
-40.05%78.79M
-38.04%90.46M
-33.58%105.19M
-30.11%118.20M
20.87%131.42M
17.14%145.99M
16.11%158.38M
12.05%169.11M
208.75%108.73M
219.30%124.63M
216.80%136.41M
218.96%150.93M
Cash Flow Statement
Net operating income
72.56%-14.53M
-87.19%-22.21M
-14.49%-17.23M
1.97%-15.38M
-478.32%-52.96M
39.63%-11.86M
-56.09%-15.05M
-31.26%-15.69M
45.36%-9.16M
7.78%-19.65M
14.73%-9.64M
-45.83%-11.95M
-56.32%-16.76M
-9.76%-21.31M
9.00%-11.31M
-99.81%-8.20M
-381.39%-10.72M
-429.50%-19.41M
-157.81%-12.43M
74.01%-4.10M
Net investment
41.49%-16.87M
-83.18%19.43M
28.27%16.85M
-1901.91%-91.63M
-707.22%-28.83M
994.25%115.50M
259.91%13.13M
-59.86%5.08M
-107.06%-3.57M
-35.36%10.55M
104.32%3.65M
126.26%12.67M
21079.67%50.56M
71095.65%16.33M
-183332.61%-84.38M
-291.45%-48.24M
---241.00K
---23.00K
---46.00K
206483.05%25.20M
Net financing
9728.24%81.84M
-100.00%0.00
-52.83%25.00K
--0.00
-1077.01%-850.00K
952110.00%95.20M
-33.75%53.00K
100.00%0.00
-72.20%87.00K
-225.00%-10.00K
174.77%80.00K
-100.10%-75.00K
459.77%313.00K
-97.32%8.00K
-221.59%-107.00K
-48.79%72.52M
-352.25%-87.00K
324.02%298.00K
-38.69%88.00K
11760.24%141.61M

Revenue

By Business

Period:
No Data

By Region

Period:
No Data

FAQs

What is the total revenue of Whitehawk Therapeutics Inc?

According to Whitehawk Therapeutics Inc's FY2025 earnings report, its total revenue reached 7.14M, with a year-on-year change of 25.98M.

What are the current assets of Whitehawk Therapeutics Inc?

According to Whitehawk Therapeutics Inc's FY2025 earnings report, its current assets were 149.01M, with a year-on-year change of 143.14.

What are the total assets of Whitehawk Therapeutics Inc?

According to Whitehawk Therapeutics Inc's FY2025 earnings report, its total assets of Whitehawk Therapeutics Inc were 150.83M, with a year-on-year change of 114.49.

What are the total liabilities of Whitehawk Therapeutics Inc?

According to Whitehawk Therapeutics Inc's FY2025 earnings report, its total liabilities of Whitehawk Therapeutics Inc were 14.52M, with a year-on-year change of -18.62.

What is the total equity of Whitehawk Therapeutics Inc?

According to Whitehawk Therapeutics Inc's FY2025 earnings report, its total equity of Whitehawk Therapeutics Inc was 136.31M, with a year-on-year change of 159.75.

What is the net operating income of Whitehawk Therapeutics Inc?

According to Whitehawk Therapeutics Inc's FY2025 earnings report, its net operating income of Whitehawk Therapeutics Inc was -114.40M, with a year-on-year change of -76.49.

What is the net investment of Whitehawk Therapeutics Inc?

According to Whitehawk Therapeutics Inc's FY2025 earnings report, its net investment of Whitehawk Therapeutics Inc was 11.89M, with a year-on-year change of -52.82.

What is the net financing of Whitehawk Therapeutics Inc?

According to Whitehawk Therapeutics Inc's FY2025 earnings report, its net financing of Whitehawk Therapeutics Inc was 94.38M, with a year-on-year change of 72496.92.

What is the Earnings Per Share (EPS) of Whitehawk Therapeutics Inc?

According to Whitehawk Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -0.44, with a year-on-year change of 81.46.

What is the net income of Whitehawk Therapeutics Inc?

According to Whitehawk Therapeutics Inc's FY2025 earnings report, its net income was -20.60M, with a year-on-year change of 67.66.

What is the net margin of Whitehawk Therapeutics Inc?

According to Whitehawk Therapeutics Inc's FY2025 earnings report, its net profit margin was -288.26, with a year-on-year change of -17.60.

What is the gross margin of Whitehawk Therapeutics Inc?

According to Whitehawk Therapeutics Inc's FY2025 earnings report, its gross margin was 89.36, with a year-on-year change of 1.13.

What is the Return on Equity (ROE) of Whitehawk Therapeutics Inc?

According to Whitehawk Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -21.82, with a year-on-year change of 72.99.

What is the Return on Assets (ROA) of Whitehawk Therapeutics Inc?

According to Whitehawk Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -18.63, with a year-on-year change of 70.35.

What is the operating profit of Whitehawk Therapeutics Inc?

According to Whitehawk Therapeutics Inc's FY2025 earnings report, its operating profit was -114.40M, with a year-on-year change of -76.49.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy